Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.58 EUR | +2.39% |
|
-5.46% | -20.69% |
06-04 | Pharma Mar Presents Encouraging Results At ASCO for Small Cell Lung Cancer | CI |
04-23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.69% | 601M | |
+2.08% | 95.18B | |
-4.34% | 37.55B | |
+75.67% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B | |
+5.92% | 9.09B |
- Stock Market
- Equities
- PHM Stock
- News Pharma Mar, S.A.
- Transcript : Pharma Mar, S.A., H1 2021 Earnings Call, Jul 30, 2021